Search research articles
Contact Us
Filters
Showing results (111-120 of 352) with videos related to
Page
of 36
Sort By:
Inflammatory Bowel Diseases
|
January 8, 2019
Anxiety But Not Depression Predicts Poor Outcomes in Inflammatory Bowel Disease
Neeraj Narula, Maria Ines Pinto-Sanchez, Natalia Causada Calo, et al.
Journal of Clinical Medicine
|
September 23, 2022
Impact of COVID-19 Pandemic on Initiation of Immunosuppressive Treatment in Immune-Mediated Inflammatory Diseases in Austria: A Nationwide Retrospective Study
Maximilian Kutschera, Valentin Ritschl, Berthold Reichardt, et al.
Gastrointestinal Endoscopy
|
May 29, 2020
Impact of various central endoscopy reading models on treatment outcome in Crohn's disease using data from the randomized, controlled, exploratory cohort arm of the BERGAMOT trial
Walter Reinisch, Daniel S Mishkin, Young S Oh, et al.
Journal of Crohn'S & Colitis
|
November 12, 2024
Use of Modified Multiplier of the Simple Endoscopic Score for Crohn's Disease Endoscopic Improvement Thresholds Enhances Effect Size Differentiation Between Adalimumab Versus Placebo: A Post Hoc Analysis of the EXTEND Trial
Emily C L Wong, Parambir S Dulai, John K Marshall, et al.
Inflammatory Bowel Diseases
|
February 26, 2011
Are inherited thrombotic risk factors associated with fibrostenosis in Crohn's disease?
Gottfried Novacek, Pavol Papay, Wolfgang Miehsler, et al.
European Journal of Gastroenterology & Hepatology
|
November 19, 2003
Do high serum levels of anti-Saccharomyces cerevisiae antibodies result from a leakiness of the gut barrier in Crohn's disease?
Marieluise Harrer, Walter Reinisch, Clemens Dejaco, et al.
The American Journal of Gastroenterology
|
September 27, 2007
6-thioguanine associated nodular regenerative hyperplasia in patients with inflammatory bowel disease may induce portal hypertension
Arnulf Ferlitsch, Alexander Teml, Walter Reinisch, et al.
Journal of Gastroenterology and Hepatology
|
March 10, 2022
Safety, pharmacokinetic, and pharmacodynamic study of sibofimloc, a novel FimH blocker in patients with active Crohn's disease
Walter Reinisch, Xavier Hébuterne, Anthony Buisson, et al.
Inflammatory Bowel Diseases
|
January 9, 2007
Impact of interobserver disagreement on phenotype-genotype associations in Crohn's disease
Anna Oefferlbauer-Ernst, Wolfgang Miehsler, Otto Eckmüllner, et al.
The American Journal of Gastroenterology
|
October 23, 2013
A randomized, open-label, non-inferiority study of intravenous iron isomaltoside 1,000 (Monofer) compared with oral iron for treatment of anemia in IBD (PROCEED)
Walter Reinisch, Michael Staun, Rakesh K Tandon, et al.
Page
of 36
Search research articles
Search
Showing results (111-120 of 352) with videos related to
Sort By:
Page
of 36
Inflammatory Bowel Diseases
|
January 8, 2019
Anxiety But Not Depression Predicts Poor Outcomes in Inflammatory Bowel Disease
Neeraj Narula, Maria Ines Pinto-Sanchez, Natalia Causada Calo, et al.
Journal of Clinical Medicine
|
September 23, 2022
Impact of COVID-19 Pandemic on Initiation of Immunosuppressive Treatment in Immune-Mediated Inflammatory Diseases in Austria: A Nationwide Retrospective Study
Maximilian Kutschera, Valentin Ritschl, Berthold Reichardt, et al.
Gastrointestinal Endoscopy
|
May 29, 2020
Impact of various central endoscopy reading models on treatment outcome in Crohn's disease using data from the randomized, controlled, exploratory cohort arm of the BERGAMOT trial
Walter Reinisch, Daniel S Mishkin, Young S Oh, et al.
Journal of Crohn'S & Colitis
|
November 12, 2024
Use of Modified Multiplier of the Simple Endoscopic Score for Crohn's Disease Endoscopic Improvement Thresholds Enhances Effect Size Differentiation Between Adalimumab Versus Placebo: A Post Hoc Analysis of the EXTEND Trial
Emily C L Wong, Parambir S Dulai, John K Marshall, et al.
Inflammatory Bowel Diseases
|
February 26, 2011
Are inherited thrombotic risk factors associated with fibrostenosis in Crohn's disease?
Gottfried Novacek, Pavol Papay, Wolfgang Miehsler, et al.
European Journal of Gastroenterology & Hepatology
|
November 19, 2003
Do high serum levels of anti-Saccharomyces cerevisiae antibodies result from a leakiness of the gut barrier in Crohn's disease?
Marieluise Harrer, Walter Reinisch, Clemens Dejaco, et al.
The American Journal of Gastroenterology
|
September 27, 2007
6-thioguanine associated nodular regenerative hyperplasia in patients with inflammatory bowel disease may induce portal hypertension
Arnulf Ferlitsch, Alexander Teml, Walter Reinisch, et al.
Journal of Gastroenterology and Hepatology
|
March 10, 2022
Safety, pharmacokinetic, and pharmacodynamic study of sibofimloc, a novel FimH blocker in patients with active Crohn's disease
Walter Reinisch, Xavier Hébuterne, Anthony Buisson, et al.
Inflammatory Bowel Diseases
|
January 9, 2007
Impact of interobserver disagreement on phenotype-genotype associations in Crohn's disease
Anna Oefferlbauer-Ernst, Wolfgang Miehsler, Otto Eckmüllner, et al.
The American Journal of Gastroenterology
|
October 23, 2013
A randomized, open-label, non-inferiority study of intravenous iron isomaltoside 1,000 (Monofer) compared with oral iron for treatment of anemia in IBD (PROCEED)
Walter Reinisch, Michael Staun, Rakesh K Tandon, et al.
Page
of 36